COMPOSITION:
Each 5 ml contains:
Cyproheptadine Hydrochloride IP 2 mg
Flavoured syrupy base q.s.
DESCRIPTION: TORACTIN Syrup contains Cyproheptadine HCI, which is an antihistaminic and antiserotonergic agent.
MECHANISM OF ACTION: Competitively antagonizes histamine at H, receptor sites. Also exhibits antiserotonin activity.
PHARMACOKINETICS: The principal metabolite found in the urine is the quaternary ammonium glucuronide conjugate of cyproheptadine. 2% to 20% is excreted in the feces, of which 34% (5.7% of the dose) is unchanged drug. At least 40% is excreted in the urine.
INDICATIONS: Toracting Syrup is mainly used as Appetite Stimulant, Prophylactic treatment of paediatric migraines; suppression of vascular headaches. Symptomatic relief of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis; amelioration of allergic reactions to blood or plasma; management of allergic pruritic symptoms, mild skin manifestations of uncomplicated urticaria and angioedema and urticaria; dermographism; adjunctive anaphylactic therapy.
DOSAGE AND ADMINISTRATION: Adults: 2 teaspoonfuls (10ml), 3-4 times a day. Children: 2 to 6 years: 1 teaspoonful (5ml), 3 times a day. 7 to 14 years: 1-2 teaspoonfuls (5 to 10ml), 3 times a day. CONTRAINDICATIONS: Hypersensitivity to antihistamines.
PRECAUTIONS: Dizziness / Drowsiness Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider. Administer without regard to meals. Administer with food if Gl upset occurs. Measure and administer prescribed dose of syrup using dosing syringe, dosing spoon, or dosing cup.
DRUG INTERACTIONS: Alcohol, CNS depressants may cause additive CNS depressant effects. MAOIS: Anticholinergic effects of cyproheptadine may increase.
SIDE- EFFECTS: Excessive perspiration; photosensitivity; rash; urticaria
STORAGE: Store at a temperature not exceeding 30°C. Protect from light. Keep out of reach of children.
PRESENTATION: 100ml bottle in Duplex Board Carton.
FOR EXPORT ONLY